These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 23303570)
1. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570 [TBL] [Abstract][Full Text] [Related]
2. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent. Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578 [TBL] [Abstract][Full Text] [Related]
3. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912 [TBL] [Abstract][Full Text] [Related]
4. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery. Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronated nanoparticles with pH- and enzyme-responsive drug release properties. Kim SW; Oh KT; Youn YS; Lee ES Colloids Surf B Biointerfaces; 2014 Apr; 116():359-64. PubMed ID: 24521699 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766 [TBL] [Abstract][Full Text] [Related]
9. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding. Wang LS; Wu LC; Lu SY; Chang LL; Teng IT; Yang CM; Ho JA ACS Nano; 2010 Aug; 4(8):4371-9. PubMed ID: 20731423 [TBL] [Abstract][Full Text] [Related]
10. A pH-Responsive Hydrogel Based on a Tumor-Targeting Mesoporous Silica Nanocomposite for Sustained Cancer Labeling and Therapy. Chen X; Liu Z Macromol Rapid Commun; 2016 Sep; 37(18):1533-9. PubMed ID: 27448182 [TBL] [Abstract][Full Text] [Related]
11. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery. Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189 [No Abstract] [Full Text] [Related]
12. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis. Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879 [TBL] [Abstract][Full Text] [Related]
13. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090 [TBL] [Abstract][Full Text] [Related]
14. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849 [TBL] [Abstract][Full Text] [Related]
16. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065 [TBL] [Abstract][Full Text] [Related]
17. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach. Varghese OP; Sun W; Hilborn J; Ossipov DA J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915 [TBL] [Abstract][Full Text] [Related]
18. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process. Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of nanocarriers with remote magnetic drug release control and enhanced drug delivery for intracellular targeting of cancer cells. Tung WL; Hu SH; Liu DM Acta Biomater; 2011 Jul; 7(7):2873-82. PubMed ID: 21439410 [TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. Luo Z; Cai K; Hu Y; Zhao L; Liu P; Duan L; Yang W Angew Chem Int Ed Engl; 2011 Jan; 50(3):640-3. PubMed ID: 21226142 [No Abstract] [Full Text] [Related] [Next] [New Search]